CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-16 | Potti Manish Director | Option exercise | +13,500 | $0.51 | $7K | 13,500 |
| 2021-12-16 | Potti Manish Director | Option exercise | +31,500 | $1.83 | $58K | 45,000 |
| 2021-12-16 | Potti Manish Director | Grant or award · Option (Right to Buy) | +16,335 | 16,335 | ||
| 2021-12-16 | Potti Manish Director | Option exercise · Option (Right to Buy) | +13,500 | 19,500 | ||
| 2021-12-16 | Potti Manish Director | Option exercise · Option (Right to Buy) | +31,500 | 87,500 | ||
| 2021-12-16 | Musunuri Shankar Chief Executive Officer | Sale | −115,000 | $5.22 | $600K | 1,145,299 |
| 2021-12-16 | Musunuri Shankar Chief Executive Officer | Grant or award · Option (Right to Buy) | +197,000 | 394,000 | ||
| 2021-12-16 | Kumar Ramesh Director | Grant or award · Option (Right to Buy) | +16,335 | 16,335 | ||
| 2021-12-16 | Kompella Uday Director | Grant or award · Option (Right to Buy) | +16,335 | 16,335 | ||
| 2021-12-16 | Fernandes Prabhavathi Director | Grant or award · Option (Right to Buy) | +16,335 | 16,335 | ||
| 2021-12-16 | Zhang Junge Director | Grant or award · Option (Right to Buy) | +16,335 | 16,335 | ||
| 2021-12-16 | Castillo Kirsten Director | Grant or award · Option (Right to Buy) | +16,335 | 16,335 | ||
| 2021-11-16 | Zhang Junge Director | Option exercise | +143,820 | $2.77 | $398K | 875,251 |
| 2021-11-16 | Zhang Junge Director | Option exercise | +1,653 | $7.56 | $12K | 876,904 |
| 2021-11-16 | Zhang Junge Director | Option exercise · Warrants (Right to Buy) | −143,820 | 0 | ||
| 2021-11-16 | Zhang Junge Director | Option exercise · Warrants (Right to Buy) | −1,653 | 0 | ||
| 2021-11-16 | Musunuri Shankar Chief Executive Officer | Sale | −115,000 | $8.04 | $925K | 1,260,299 |
| 2021-11-16 | Musunuri Shankar Chief Executive Officer | Grant or award · Option (Right to Buy) | +197,000 | 197,000 | ||
| 2021-11-16 | Subramanian Sanjay Chief Financial Officer | Grant or award · Option (Right to Buy) | +35,560 | 35,560 | ||
| 2021-11-03 | Zhang Junge Director | Sale | −150,300 | $17.32 | $2.6M | 731,431 |
Page 7 of 27 · 525 trades